🇰🇷 Avmapki Fakzynja Co-Pack in South Korea

Avmapki Fakzynja Co-Pack (AVUTOMETINIB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: VERASTEM INC
  • Status: likely_approved

Avmapki Fakzynja Co-Pack in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Avmapki Fakzynja Co-Pack approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Avmapki Fakzynja Co-Pack in South Korea?

VERASTEM INC holds the South Korean marketing authorisation.